ICTR in the News: Study Reveals Racial Disparities in Clinical Trial Recruitment

  Recruitment strategy that pairs use of electronic medical records with postal mailings shows cost-effectiveness and increased participation of under-represented groups   This article, courtesy of Newswise, discusses research funded by the ICTR.   As electronic medical records (EMR) become ubiquitous in health care settings, scientists are increasingly turning to electronic-based recruitment methods to encourage participation in clinical trials. However, little is known about how this use of technology compares to more traditional clinical trial recruitment strategies, and some researchers worry that an overreliance on technology has the potential to exclude an eligible and interested diverse participant population. In a … Continue reading

Apply for the Francis S. Collins Scholars (FCS) Program in Neurofibromatosis Clinical and Translational Research

The deadline for application submission is December 21, 2020. NTAP is now seeking applications for the Francis Collins Scholars (FCS) Program in Neurofibromatosis Clinical and Translational Research, a key program of the Neurofibromatosis Therapeutic Acceleration Program (NTAP) at Johns Hopkins University. Since its founding in 2012, NTAP has been dedicated to passionately supporting individual researchers, scientific teams, organizations and companies that will make significant impact and improve the lives of people living with NF1. Candidates must be in their last stages of post-doctoral training or in the first seven years of faculty appointment, have patient-care responsibilities, a commitment to patient-focused … Continue reading

Clinical Research Unit (CRU) Utilization during the COVID-19 Pandemic

Scheduling Appointments Only research that has approval to start may schedule visits in the CRU. Do not schedule a visit for your study until you have IRB approval to begin/resume your study. Before you start scheduling visits for your study, email your letter from the IRB approving the resumption of your study to Shernice Madison at smadison@jhu.edu. A short “re-boot meeting” will be scheduled between the CRU and the study team to go over any changes to your study. Shernice will assist with this. When you schedule your visit in CRU online, add a comment in the “note” section with … Continue reading

Learn About the National COVID Cohort Collaborative (N3C) Data Enclave

The National Center for Advancing Translational Sciences (NCATS) and the National Center for Data to Health (CD2H), in partnership with experts from Observational Health Data Sciences and Informatics (OHDSI), PCORnet, the Accrual to Clinical Trials (ACT) network, and TriNetX, announce the launch of the National COVID Cohort Collaborative (N3C) Data Enclave.

Study Adds to Evidence That Odor-Sensing Cells in the Nose Are the Key Entry Point for SARS CoV-2

Study Adds to Evidence That Odor-Sensing Cells in the Nose Are the Key Entry Point for SARS CoV-2 Scientists at Johns Hopkins Medicine, experimenting with a small number of human cell samples, report that the “hook” of cells used by SARS-CoV-2 to latch onto and infect cells is up to 700 times more prevalent in the olfactory supporting cells lining the inside of the upper part of the nose than in the lining cells of the rest of the nose and windpipe that leads to the lungs. These supporting cells are necessary for the function/development of odor-sensing cells. The findings, … Continue reading

K-to-R Seminar September 30

Get that Paper out the Door! Pearls and Pitfalls of Publishing This session will be offered via the School of Medicine’s Office of Faculty Development. Please register as soon as possible, since space is limited. If you have difficulty registering, please email Mia Terkowitz at mterkw1@jhmi.edu. Session Information Been quarantined lately? Do you find yourself wishing you had the: time; interest; energy; inspiration; motivation; dedication; organization; or know-how to get those papers started, worked-on, finished, and submitted for publication? Yes, writing is hard! But in academic medicine, writing is your job, so do your job every day! In this active … Continue reading

How to Fill Research Positions during COVID

Here is a brief summary of options for faculty/departments to consider for obtaining talent. We strongly suggest that you consider a combination of all of these options. The first two will be quicker to bring talent on but they will not be available as long. The temporary employee process takes a little longer to obtain the talent, but the talent will be able to commit for 6-18 months. Recruiters are reaching out to those that signed up for redeployment. If people are available, they could be brought on quickly. When people respond they want to see a job description, know … Continue reading

Nominations Now Open for the Urban Health Institute 2020 Henrietta Lacks Memorial Award

The Urban Health Institute is now accepting applications for the 2020 Henrietta Lacks Memorial Award. Community-based organizations that have partnered with faculty or staff at Johns Hopkins for a minimum of two years can apply or be nominated for this $15,000 award! We are grateful for the work community-based organizations do each day to create a healthier Baltimore and advance healthy equity for all. The Henrietta Lacks Memorial Award seeks to recognize those change agents and honor Henrietta Lacks’ legacy as a contributor to her community and health. Apply Urban Health Institute Website    

Apply for a Boost or Propel Research Award by September 14

We are currently accepting applications for our Boost and Propel awards. Boost and Popel are clinical research grants that award Clinical Research Unit (CRU) services, including research space, overnight beds, phlebotomy, specialized research nursing, and CRU-based imaging (i.e. DXA, CV core) to investigators, based on scientific merit.  

Johns Hopkins Receives $35 Million in Funding from Department of Defense for COVID-19 Blood Plasma Trials

This article discusses the work of Daniel Hanley, MD ICTR director for multi-site clinical trials.   Johns Hopkins researchers have received $35 million in funding from the U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), on behalf of the Defense Health Agency, for two nationwide clinical trials to test the effectiveness of a convalescent blood plasma outpatient treatment. The treatment is a transfusion of a blood product from COVID-19 survivors that contains antibodies that may help the patient’s immune system fight the virus. The randomized double blind trials totaling 1,100 people … Continue reading

Johns Hopkins Researcher Shmuel Shoham Discusses his COVID-19 Research

“It’s been very exciting to see so many COVID-19 survivors step up to donate their antibody-rich blood to save other lives.” — Shmuel Shoham, M.D. Shmuel Shoham, M.D., has spent most of his nine years at Johns Hopkins diagnosing and caring for patients with infectious diseases, such as pneumonia. But when COVID-19 cases began to soar — with no cure in sight — the associate professor of medicine in the transplant and oncology infectious diseases program felt compelled to act. Building on previous research to treat influenza using antibodies from survivors’ blood, Shoham helped form a consortium of experts to … Continue reading